Combining radiolabelled therapies for neuroendocrine neoplasms
Nat Rev Endocrinol
.
2020 Jul;16(7):347-348.
doi: 10.1038/s41574-020-0367-3.
Authors
Andrea Frilling
1
,
Ashley Kieran Clift
2
3
Affiliations
1
Department of Surgery & Cancer, Imperial College London, London, UK. a.frilling@imperial.ac.uk.
2
Department of Surgery & Cancer, Imperial College London, London, UK.
3
NHS Nightingale Hospital London, London, UK.
PMID:
32382045
DOI:
10.1038/s41574-020-0367-3
No abstract available
Publication types
Comment
MeSH terms
Holmium
Humans
Liver Neoplasms*
Lutetium
Neuroendocrine Tumors*
Radioisotopes
Substances
Holmium-166
Radioisotopes
Lutetium
Lutetium-177
Holmium